Novartis strengthens executive committee further
Novartis this week announced changes to its senior leadership team to support the implementation of its strategic priorities. These changes include the appointment of Shannon Klinger in the elevated and expanded role of chief ethics, risk, and compliance officer, effective April 1.
Related articles
-
ArticleNovartis to pay $347M to resolve FCPA investigations
Novartis will pay nearly $347 million in combined criminal and civil penalty settlements with U.S. authorities to resolve all FCPA investigations into historical conduct by the company and its subsidiaries.
-
WebcastCPE Webcast: How to Build Holistic Risk and Resilience Management
Risk, compliance, and business continuity teams often run in parallel, but what if they worked better together? As risks become more interconnected and the pressure to respond quickly grows, companies are realizing that a siloed approach doesn’t cut it anymore.
-
WebcastOct 16 | TPRM - Best Practices for Calculating Inherent Risk
Join this webinar with ProcessUnity to hear expert advice and best practices on how to calculate inherent risk and put it to work for your program.